Generate a study information data.frame for use in reports
Source:R/util-MakeStudyInfo.R
MakeStudyInfo.Rd`r lifecycle::badge("stable")`
Generate a study info table summarizing study metadata.
Arguments
- dfGroups
`data.frame` Group-level metadata dictionary. Created by passing CTMS site and study data to [MakeLongMeta()]. Expected columns: `GroupID`, `GroupLevel`, `Param`, `Value`.
- lStudyLabels
`list` A list containing study labels. Default is NULL.
- lStudy
`deprecated` Study information as a named list.
Examples
MakeStudyInfo(gsm.core::reportingGroups)
#> Param Value Description
#> 1 studyid AA-AA-000-0000 Studyid
#> 2 nickname OAK-38 Nickname
#> 3 protocol_title Protocol Title P Protocol Title
#> 4 status Active Status
#> 5 num_plan_site 150 Num Plan Site
#> 6 num_plan_subj 1000 Num Plan Subj
#> 7 act_fpfv 2012-01-02 Act Fpfv
#> 8 est_fpfv 2012-01-07 Est Fpfv
#> 9 est_lplv 2012-07-24 Est Lplv
#> 10 est_lpfv 2012-03-26 Est Lpfv
#> 11 therapeutic_area Virology Therapeutic Area
#> 12 protocol_indication Hematology Protocol Indication
#> 13 phase P2 Phase
#> 14 product Product Name 14 Product
#> 15 SiteTarget 150 Site Target
#> 16 ParticipantTarget 1000 Participant Target
#> 17 ParticipantCount 767 Participants Enrolled
#> 18 SiteCount 144 Sites Enrolled
#> 19 PercentSitesActivated 96 Percent Sites Activated
#> 20 SiteActivation 144 / 150 (96%) Site Activation
#> 21 PercentParticipantsEnrolled 76.7 Percent Participants Enrolled
#> 22 ParticipantEnrollment 767 / 1000 (76.7%) Participant Enrollment
MakeStudyInfo(gsm.core::reportingGroups, list(SiteCount = "# Sites"))
#> Param Value Description
#> 1 studyid AA-AA-000-0000 Studyid
#> 2 nickname OAK-38 Nickname
#> 3 protocol_title Protocol Title P Protocol Title
#> 4 status Active Status
#> 5 num_plan_site 150 Num Plan Site
#> 6 num_plan_subj 1000 Num Plan Subj
#> 7 act_fpfv 2012-01-02 Act Fpfv
#> 8 est_fpfv 2012-01-07 Est Fpfv
#> 9 est_lplv 2012-07-24 Est Lplv
#> 10 est_lpfv 2012-03-26 Est Lpfv
#> 11 therapeutic_area Virology Therapeutic Area
#> 12 protocol_indication Hematology Protocol Indication
#> 13 phase P2 Phase
#> 14 product Product Name 14 Product
#> 15 SiteTarget 150 Site Target
#> 16 ParticipantTarget 1000 Participant Target
#> 17 ParticipantCount 767 Participant Count
#> 18 SiteCount 144 # Sites
#> 19 PercentSitesActivated 96 Percent Sites Activated
#> 20 SiteActivation 144 / 150 (96%) Site Activation
#> 21 PercentParticipantsEnrolled 76.7 Percent Participants Enrolled
#> 22 ParticipantEnrollment 767 / 1000 (76.7%) Participant Enrollment